The outcome of integrated motivational interviewing and cognitive-behavioral therapy in Egyptian patients with substance use disorder

IF 1.5 Q3 PSYCHIATRY Middle East Current Psychiatry Pub Date : 2023-12-18 DOI:10.1186/s43045-023-00377-3
Mohamed Hossam EL-Din Abdel Moneam, Nesreen Mohsen, Lobna AbuBakr Azzam, Yasser Abdel Razek Elsayed, Ahmed Adel Alghonaimy
{"title":"The outcome of integrated motivational interviewing and cognitive-behavioral therapy in Egyptian patients with substance use disorder","authors":"Mohamed Hossam EL-Din Abdel Moneam, Nesreen Mohsen, Lobna AbuBakr Azzam, Yasser Abdel Razek Elsayed, Ahmed Adel Alghonaimy","doi":"10.1186/s43045-023-00377-3","DOIUrl":null,"url":null,"abstract":"The authors aimed to evaluate the outcome of combined motivational interviewing and cognitive-behavioral therapy (MICBT) for substance use disorder compared to the twelve-step facilitation (TSF) therapy in terms of retention in the treatment program, the number of relapses, and the period of abstinence after discharge, coping with craving, and modification of problematic behaviors. This randomized controlled trial included 60 individuals with a substance use disorder. Participants were randomly allocated to equal groups. The MICBT group received 20 sessions of approximately 90 min of MICBT group therapy. The NA (control) group was assigned 20 narcotic anonymous (NA)-oriented TSF group therapy sessions. The assessment was conducted 3 and 6 months after the intervention. The implementation of MICBT in a group setting leads to a significant decline in the number of days of drug use in 3 months of follow-up (P = 0.006) and 6 months of follow-up (P < 0.001), an increase in the number of days of abstinence in 3 months of follow-up (P = 0.008) and 6 months of follow-up (P < 0.001), a longer time to the first lapse (P < 0.001), and a higher percentage of attendance days for treatment (P < 0.001) in comparison to NA groups. MICBT intervention was a significant positive predictor of several urge-specific coping strategies and several general strategies for drugs (P < 0.05). Using MICBT in group settings presents several benefits in clinical contexts.","PeriodicalId":38653,"journal":{"name":"Middle East Current Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Middle East Current Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s43045-023-00377-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

The authors aimed to evaluate the outcome of combined motivational interviewing and cognitive-behavioral therapy (MICBT) for substance use disorder compared to the twelve-step facilitation (TSF) therapy in terms of retention in the treatment program, the number of relapses, and the period of abstinence after discharge, coping with craving, and modification of problematic behaviors. This randomized controlled trial included 60 individuals with a substance use disorder. Participants were randomly allocated to equal groups. The MICBT group received 20 sessions of approximately 90 min of MICBT group therapy. The NA (control) group was assigned 20 narcotic anonymous (NA)-oriented TSF group therapy sessions. The assessment was conducted 3 and 6 months after the intervention. The implementation of MICBT in a group setting leads to a significant decline in the number of days of drug use in 3 months of follow-up (P = 0.006) and 6 months of follow-up (P < 0.001), an increase in the number of days of abstinence in 3 months of follow-up (P = 0.008) and 6 months of follow-up (P < 0.001), a longer time to the first lapse (P < 0.001), and a higher percentage of attendance days for treatment (P < 0.001) in comparison to NA groups. MICBT intervention was a significant positive predictor of several urge-specific coping strategies and several general strategies for drugs (P < 0.05). Using MICBT in group settings presents several benefits in clinical contexts.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对埃及药物使用障碍患者进行动机访谈和认知行为疗法综合治疗的结果
作者的目的是评估动机访谈和认知行为疗法(MICBT)与十二步骤促进疗法(TSF)相比,对药物使用障碍的治疗效果,包括在治疗计划中的保持率、复发次数、出院后的戒断时间、对渴求的应对以及问题行为的改变。这项随机对照试验包括 60 名药物使用障碍患者。参与者被随机分配到相同的小组。MICBT 组接受 20 次约 90 分钟的 MICBT 团体治疗。NA(对照)组则被分配接受 20 次以匿名麻醉品(NA)为导向的 TSF 团体治疗。评估在干预 3 个月和 6 个月后进行。与 NA 组相比,在小组环境中实施 MICBT 后,吸毒天数在 3 个月的随访(P = 0.006)和 6 个月的随访(P < 0.001)中显著下降,戒毒天数在 3 个月的随访(P = 0.008)和 6 个月的随访(P < 0.001)中增加,首次失禁的时间延长(P < 0.001),参加治疗的天数百分比提高(P < 0.001)。MICBT 干预对几种针对冲动的应对策略和几种针对毒品的一般策略具有显著的正向预测作用(P < 0.05)。在小组环境中使用 MICBT 可为临床带来多种益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Middle East Current Psychiatry
Middle East Current Psychiatry Medicine-Psychiatry and Mental Health
CiteScore
3.00
自引率
0.00%
发文量
89
审稿时长
9 weeks
期刊最新文献
Virtual reality in telepsychiatry is a new horizon for immersive mental health therapy Status and sociodemographic correlates of pathological internet use among adolescents in Jordan: a cross-sectional study Post-traumatic stress disorder among nursing students at Palestine Polytechnique University during the Gaza war and the attack on the health care system Psychological assessment of violent behaviors in schizophrenic patients followed up in My EL Hassan health center of Kenitra, Morocco Burnout syndrome, anxiety, and depression symptoms among workers in radiation field
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1